Fact CheckerSign in

NCT01091480Recruiting

French Hypertrophic Cardiomyopathy Observatory

Source: ClinicalTrials.gov · Last updated 21 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment)

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
8 Mar 2010
Start date
Jan 2010
Primary completion date
Dec 2023
Lead sponsor
French Cardiology Society
NCT number
NCT01091480

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From Jan 2010 to the primary completion date, Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Expressed refusal to participate in the study
  • Significant aortic stenosis (\<1 cm ²)

Who the study is looking for

  • Age ≥ 15 years old
  • Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic

Age in the registry: 15 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
European Georges Pompidou Hospital
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.